Shen L - Search Results

1

Baseline derived neutrophil-to-lymphocyte ratio as a prognostic biomarker for non-colorectal gastrointestinal cancer patients treated with immune checkpoint blockade.

Li S, Zou J, Liu C, Jiao X, Gong J, Li J, Wang Z, Lu M, Lu Z, Shen L. Li S, et al. Among authors: shen l. Clin Immunol. 2020 Mar;212:108345. doi: 10.1016/j.clim.2020.108345. Epub 2020 Jan 15. Clin Immunol. 2020. PMID: 31953149 Free article.

2

[Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].

Gong JF, Zhang XD, Li J, Di LJ, Jin ML, Shen L. Gong JF, et al. Among authors: shen l. Ai Zheng. 2007 Aug;26(8):890-4. Ai Zheng. 2007. PMID: 17697554 Free article. Chinese.

3

[Application of sandostatin in malignant bowel obstruction].

Li J, Jing ML, Shen L. Li J, et al. Among authors: shen l. Zhonghua Wei Chang Wai Ke Za Zhi. 2007 Sep;10(5):479-81. Zhonghua Wei Chang Wai Ke Za Zhi. 2007. PMID: 17851794 Chinese.

4

[Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].

Zhang XD, Shen L, Li J, Li Y, Li J, Zhang XT, Jin ML. Zhang XD, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2007 Jun;29(6):474-7. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17974288 Clinical Trial. Chinese.

5

A phase II trial of paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus.

Zhang X, Shen L, Li J, Li Y, Li J, Jin M. Zhang X, et al. Among authors: shen l. Am J Clin Oncol. 2008 Feb;31(1):29-33. doi: 10.1097/COC.0b013e3181131ca9. Am J Clin Oncol. 2008. PMID: 18376224 Clinical Trial.

6

[Polymorphisms of UGT1A gene and irinotecan toxicity in Chinese colorectal cancer patients].

Wang Y, Xu JM, Shen L, Xu N, Wang JW, Jiao SC, Zhang JS, Song ST, Li J, Bao HY, Yang L, Li F. Wang Y, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2007 Dec;29(12):913-6. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18478930 Chinese.

7

[Irinotecan plus fuorouracil/leucovorin (FOLFIRI) as a second line chemotherapy for refractory or metastatic colorectal cancer].

Li J, Xu JM, Li J, Zhang XD, Bai Y, Chu YP, Wang YH, Liu DQ, Jin ML, Shen L. Li J, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):225-7. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18756942 Clinical Trial. Chinese.

8

[Retrospective study on regimens of capecitabine-based chemotherapy in the treatment for advanced gastric cancer].

Zhang J, Xiao Y, Lu M, Li J, Zhang XD, Li Y, Shen L. Zhang J, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2009 Apr;31(4):312-5. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19615292 Chinese.

9

[Epirubicin combined with DDP and 5-Fu for treatment of advanced gastric cancer].

Lu M, Shen L, Li J, Li Y, Zhang XD. Lu M, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2009 May;31(5):392-5. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19799092 Clinical Trial. Chinese.

10

[Oxaliplatin-based regimen for the treatment of advanced or metastatic gastric/esophagogastric junction cancer].

Li J, Lu M, Shen L, Zhang XD, Li Y. Li J, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2009 Dec;31(12):933-6. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 20193337 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,522 results

Search Page

Filters